Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Probiotics and Irritable Bowel Syndrome: Rationale, Putative Mechanisms, and Evidence of Clinical Efficacy

Camilleri, Michael · 2006 · Journal of Clinical Gastroenterology

Abstract

The irritable bowel syndrome (IBS) follows an acute, presumably infectious diarrheal illness in approximately 15% of patients. There may be a persistent, mild inflammatory state with changes in mucosal function or structure. Changes in the colonic bacterial flora reported in IBS seem related to predominant bowel. Colonic bacteria normally metabolize nutrients with the formation of gas and short chain fatty acids. The latter may induce propulsive contractions and accelerate colonic transit or they may enhance fluid and sodium absorption in the colon. This review addresses the mechanisms, rationale and current evidence for the efficacy of probiotics, including Lactobacilli, Bifidobacteria, and VSL#3, in the treatment of IBS. The mechanisms influenced by probiotics include immune function, motility, and the intraluminal milieu. Probiotics may suppress the low-grade inflammation associated with IBS or restore normal local immune function. Lactobacilli and Bifidobacteria subspecies are able to deconjugate and absorb bile acids, potentially reducing the colonic mucosal secretion of mucin and fluids that may contribute to functional diarrhea or IBS with diarrhea. Therapeutic trials show the potential benefit of Bifidobacteria or Lactobacilli species alone or in the specific probiotic combination, VSL#3, on symptoms in IBS. Colonic transit was retarded in IBS patients treated with VSL#3 without induction of significant changes in bowel function. In summary, probiotics are promising t…

Overview

Integrity signals

Registry

Crossref · 10.1097/00004836-200603000-00020

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 41 references

Research works printed but not linked: 6

  1. Shanahan, 2005, Am J Physiol, 288, G417
  2. Barbara, 2005, Gastroenterology, 128, A
  3. Cenac, 2005, Gastroenterology, 128, A
  4. Luman, 1995, Eur J Gastroenterol Hepatol, 7, 641
  5. Chadwick, 1979, J Lab Clin Med, 94, 661
  6. Bampton, 2002, Am J Physiol, 282, G443

Cited by

See all 116

Metadata

Authors
Camilleri, M.
Affiliations
Mayo Clinic (US)
Corresponding author
Camilleri, Michael
Venue
Journal of Clinical Gastroenterology
Published
2006-03
Volume
40
Issue
3
Pages
264-269
ISSN
0192-0790 (ISSN-L)
OpenAlex
W2164343942
Cited by
106
References
41
Citations by year
2025: 1 · 2024: 2 · 2023: 1 · 2021: 2 · 2019: 2 · 2018: 1 · 2017: 5 · 2016: 1 · 2015: 7 · 2014: 7 · 2013: 5 · 2012: 7
FWCI
2.29
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
irritable bowel syndrome, probiotics, lactobacilli, Bifidobacterium, VSL#3, short-chain fatty acids, colonic transit, bile acid deconjugation, mucin secretion, low-grade inflammation, functional diarrhea, probiotic efficacy
MeSH terms
Bifidobacterium, Humans, Lactobacillus, Probiotics, Irritable Bowel Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Probiotics and Irritable Bowel Syndrome: Rationale, Putative Mechanisms, and Evidence of Clinical Efficacy. https://app.cochat.ai/papers/10.1097/00004836-200603000-00020
The paper
Camilleri, M. (2006). Probiotics and Irritable Bowel Syndrome: Rationale, Putative Mechanisms, and Evidence of Clinical Efficacy. Journal of Clinical Gastroenterology. https://doi.org/10.1097/00004836-200603000-00020

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.